Blood immune cells from people with HIV on antiviral regimens that contain tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF) have differential metabolic signatures
Related Posts
Mogar N, Zhang D, Heaney AP. A Bridge Too Far? Towards Medical Therapy for Clinically Nonfunctioning Pituitary Tumors. Int J Mol Sci. 2025 Jun 19;26(12):5898.[...]
Hevener AL, Correa SM. Metabolic Messengers: oestradiol. Nat Metab. 2025 Jun;7(6):1114-1122. doi: 10.1038/s42255-025-01317-7. Epub 2025 Jun 24. PMID: 40562968.
LeVee A, Peluso E, Lechner MG, Ruel N, Mortimer J, Kang I, Tsai K. Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in[...]